Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Oncology/Immunology363.37M57.66%
Other Ventures266.84M42.34%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
People’s Republic of China (PRC)452.41M71.79%
US and Others177.79M28.21%